Charlie Bavington

Charlie has a Ph.D. in BioChemistry from Edinburgh University and over 20 years of experience in marine biotechnology research & development taking products from conception through to pilot trials. Prior to OCEANIUM, Charlie founded Glycomar, a biotechnology company focusing on research and development of marine-based products for the healthcare, pharma, personal care and nutritional markets. Charlie is an inventor on 5 patents and author of 15 peer-reviewed research papers and book chapters.